Site Search

Share

X

Search Results

Governor Murphy Sets Sights on Affordability Concerns in 2025, Advocates Applaud & Urge Lawmakers to Prioritize Patients across Cancer Continuum

The following is a statement from American Cancer Society Cancer Action Network (ACS CAN) New Jersey Government Relations Director Quinton Law: “As anybody touched by the disease can tell you, cancer demands a high price. ... This is the case for patients across the cancer continuum. New Jerseyans are looking for state leaders to intervene and prevent the costs of care from trending upward and potentially trapping them in a lifetime of medical debt. Cancer patients and survivors throughout the state were ... the health and wellbeing of a key group of New Jersey’s workforce not only exposes the workers to preventable illness and the accompanying cost burden, but it also costs casinos and the state through increased health, life and fire insurance premiums, workers compensation payments, ...

House Votes to Remove Barriers to Biomarker Testing

... state.  The following is a statement from Leo Almeida, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Ohio: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. We have heard countless stories of the difficulties patients face in attempting to access this critical testing. It’s time for that to change. "This legislation will help ...

Florida needs to increase access to game-changing cancer tests

FORT MYERS, FL --  The most rewarding part of our roles as oncology providers is the opportunity to extend and enrich lives. It enables people to witness cherished milestones such as a ... a transformative phase with the growing use of personalized medicine. In tandem with the American Cancer Society Cancer Action Network (ACS CAN), we at Florida Cancer Specialists & Research Institute (FCS) are working to improve access to biomarker testing, including innovative ... patients who could benefit from the testing are more likely to go through failed treatments. At FCS, we are acutely aware of the long-term cost savings associated with biomarker testing that reduces the financial burden on the health care system. The ability to tailor therapies to ...

Louisiana Elected Officials Increase Access to Care for Cancer Patients

Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Kimberly Hughes Baton Rouge, LA –“The Louisiana legislature recently passed legislation that will improve access to care for cancer patients through co-pay accumulator legislation and the expansion of coverage for biomarker testing.  “Many cancer patients have difficulty affording the cost of their prescription drugs. In a co-pay accumulator program, co-pay assistance would not count toward the patients’ out-of-pocket costs. ...

Legislation Introduced to Revolutionize Cancer Treatment in Maine

... to receive biomarker testing – a routine step in accessing personalized medicine treatments that has become an increasingly important part of cancer care in recent years due to its significant impact in improving survivorship and quality of life. Progress in the fight against cancer has been in part due to advances in biomarker testing which allows physicians to match patients with ... some biomarker testing for some patients, meaning the most appropriate test for a patient may not be covered. As a result, too many Mainers can’t access such testing, which can contribute to disparities in access to the most appropriate and effective treatments. LD 1577 would address ...

Delegate Westfall files legislation aimed at improving health outcomes in West Virginia

CHARLESTON, W. Va. –Delegate Steve Westfall recently introduced legislation that would increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due to several barriers, including lack of coverage by health insurance and Medicaid programs, which this legislation would fix. “This bill expands coverage of biomarker testing so more ...

California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments

... Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. But to determine if a patient will benefit from certain targeted therapies, doctors ... Ogden-Smith, California Legislative Director for the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of ...

Senate Votes to Remove Barriers to Precision Treatments

... state.  The following is a statement from Allie Kast, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Indiana: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. Over the past few months, we have heard countless stories of the difficulties patients face in attempting to access this critical testing. It’s time for that to change. "This legislation will help ...

Expand Access to Biomarker Testing in Iowa

Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN Iowa & Partners Support  SSB 3001   This bill would increase access to biomarker testing, which is a necessary first step to accessing precision medicine.  Precision medicine includes targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. Timely access to guideline-indicated comprehensive biomarker testing will enable more patients to access the most effective treatments for their disease and can potentially help achieve the triple aim of health care: better health outcomes, improved quality of life and reduced costs.  This legislation will ensure Iowans covered by Medicaid and ...

House Committee Passes Legislation Aimed at Improving Health Outcomes for Ohioans

The following is a statement from Leo Almeida, government relations director, American Cancer Society Cancer Action Network (ACS CAN)   COLUMBUS, OHIO – “Today, the House Insurance Committee passed legislation that would increase access to biomarker testing. This legislation will help address a significant barrier and bring the promise of precision medicine to more Ohioans, no matter their income or where they live. Biomarker testing opens the door to targeted therapies, which can provide many benefits to patients, including better outcomes, improved quality of life, and, in some cases, reduced costs from bypassing ineffective therapies. “ACS CAN extends its gratitude to Rep. White for sponsoring this ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy